The 121 amino acid isoform of vascular endothelial growth factor is move strongly tumorigenic than other splice variants in vivo

Citation
Ht. Zhang et al., The 121 amino acid isoform of vascular endothelial growth factor is move strongly tumorigenic than other splice variants in vivo, BR J CANC, 83(1), 2000, pp. 63-68
Citations number
24
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
BRITISH JOURNAL OF CANCER
ISSN journal
00070920 → ACNP
Volume
83
Issue
1
Year of publication
2000
Pages
63 - 68
Database
ISI
SICI code
0007-0920(200007)83:1<63:T1AAIO>2.0.ZU;2-X
Abstract
Vascular endothelial growth factor (VEGF) is known to occur as at least six differentially spliced variants, giving rise to mature isoforms containing 121, 145, 165, 183, 189 and 206 amino acids. However, little is yet known concerning the in vivo activities of this differential splicing. Stably tra nsfected MCF-7 breast carcinoma cells were constructed that secreted compar able amounts of the 121, 165 or 189 isoforms. Rabbit corneal angiogenesis a ssays showed the VEGF121 transfectant to have much greater angiogenic activ ity than the 165 or 189 expressing MCF-7 cells. While the VEGF121-expressin g MCF-7 cells were reproducibly more tumorigenic than the control transfect ants, this was not the case with the VEGF165- or VEGF189-expressing cells. More surprising was the observation that VEGF189 located to the nucleus, co nsistent with the presence of a highly conserved nuclear localization seque nce in exon 6a that is expressed in VEGF189 but not 121 or 165. It was conc luded that the VEGF121 isoform is both more angiogenic and tumorigenic than are the 165 and 189 isoforms. This is probably due to the ability of the 1 21 isoform, unlike the 165 and 189 isoforms, to freely diffuse from the cel ls producing it. (C) 2000 Cancer Research Campaign.